| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |